These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 38268569)

  • 1. The Role of Type 2 Diabetes Mellitus-Related Risk Factors and Drugs in Hepatocellular Carcinoma.
    Mai Y; Meng L; Deng G; Qin Y
    J Hepatocell Carcinoma; 2024; 11():159-171. PubMed ID: 38268569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes.
    Shi T; Kobara H; Oura K; Masaki T
    J Hepatocell Carcinoma; 2021; 8():45-55. PubMed ID: 33604315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.
    Mantovani A; Targher G
    Ann Transl Med; 2017 Jul; 5(13):270. PubMed ID: 28758096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies.
    Vetrano E; Rinaldi L; Mormone A; Giorgione C; Galiero R; Caturano A; Nevola R; Marfella R; Sasso FC
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis.
    Bi Y; Yin B; Fan G
    Hereditas; 2021 Apr; 158(1):14. PubMed ID: 33865459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options.
    Zhang C; Liu S; Yang M
    Front Endocrinol (Lausanne); 2021; 12():808526. PubMed ID: 35002979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma.
    Qi Y; Fan L; Ran D; Xu J; Wang Y; Wu J; Zhang Z
    J Oncol; 2021; 2021():7764817. PubMed ID: 34691178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.
    Ueyama M; Nishida N; Korenaga M; Korenaga K; Kumagai E; Yanai H; Adachi H; Katsuyama H; Moriyama S; Hamasaki H; Sako A; Sugiyama M; Aoki Y; Imamura M; Murata K; Masaki N; Kawaguchi T; Torimura T; Hyogo H; Aikata H; Ito K; Sumida Y; Kanazawa A; Watada H; Okamoto K; Honda K; Kon K; Kanto T; Mizokami M; Watanabe S
    J Gastroenterol; 2016 Apr; 51(4):370-9. PubMed ID: 26337813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies.
    Chen J; Song S; Li X; Bian D; Wu X
    Saudi J Gastroenterol; 2022; 28(2):92-100. PubMed ID: 34810377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis.
    Sufyan M; Ali Ashfaq U; Ahmad S; Noor F; Hamzah Saleem M; Farhan Aslam M; El-Serehy HA; Aslam S
    Saudi J Biol Sci; 2021 Oct; 28(10):5518-5525. PubMed ID: 34588861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
    Reeves HL; Zaki MY; Day CP
    Dig Dis Sci; 2016 May; 61(5):1234-45. PubMed ID: 26921078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
    Doycheva I; Zhang T; Amjad W; Thuluvath PJ
    J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.
    Peiseler M; Schwabe R; Hampe J; Kubes P; Heikenwälder M; Tacke F
    J Hepatol; 2022 Oct; 77(4):1136-1160. PubMed ID: 35750137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows.
    Costante F; Airola C; Santopaolo F; Gasbarrini A; Pompili M; Ponziani FR
    World J Gastrointest Oncol; 2022 Sep; 14(9):1622-1636. PubMed ID: 36187401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review.
    Zaman CF; Sultana J; Dey P; Dutta J; Mustarin S; Tamanna N; Roy A; Bhowmick N; Khanam M; Sultana S; Chowdhury S; Khanam F; Sakibuzzaman M; Dutta P
    Cureus; 2022 Sep; 14(9):e29657. PubMed ID: 36320966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to Cancer.
    Manilla V; Santopaolo F; Gasbarrini A; Ponziani FR
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and prognosis of hepatocellular carcinoma in patients with diabetes.
    Nakatsuka T; Tateishi R
    Clin Mol Hepatol; 2023 Jan; 29(1):51-64. PubMed ID: 35903020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.